[ACRS] QoQ Quarter Result on 31-Dec-2018 [#Q4]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
18-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -17.75%
YoY- -68.10%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 983 5,865 5,041 3,669 1,628 3,676 1,118 -8.21%
PBT -23,138 -49,876 -37,565 -38,551 -32,740 -31,218 -30,229 -16.31%
Tax 32,733 18,504 0 -958 0 1,500 0 -
NP -55,319 -49,876 -37,565 -38,551 -32,740 -31,218 -30,229 49.55%
Tax Rate - - - - - - - -
Total Cost 56,302 55,741 42,606 42,220 34,368 34,894 31,347 47.70%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin -5,627.57 -850.40 -745.19 -1,050.72 -2,011.06 -849.24 -2,703.85 62.94%
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
EPS -1.34 -1.21 -0.91 -0.99 -1.06 -1.01 -0.98 23.16%
EPS Diluted -1.34 -1.21 -0.91 -0.99 -1.06 -1.01 -0.98 23.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.